Galapagos | GLPG - Debt

Stock Price
29.06
Daily Change
-0.50 -1.69%
Monthly
0.41%
Yearly
14.86%
Q1 Forecast
27.85

Galapagos reported EUR7.5M in Debt for its fiscal quarter ending in September of 2025.





Debt Change Date
argenx SE USD 43.15M 4.1M Jun/2025
AstraZeneca USD 32.63B 207M Sep/2025
Biogen USD 6.29B 1.7M Dec/2025
Genmab DKK 148M 5M Jun/2025
Gilead Sciences USD 24.94B 5M Sep/2025
GlaxoSmithKline GBP 17.75B 396M Sep/2025
GRIFOLS EUR 8.82B 1.23B Jun/2025
Hikma Pharmaceutical USD 1.56B 252M Jun/2025
Incyte USD 40.41M 855K Dec/2025
Merck EUR 9.4B 704M Jun/2025
Neurocrine Biosciences USD 428.4M 10.7M Sep/2025
Novartis USD 32.64B 1.37B Jun/2025
Roche Holding CHF 33.03B 1.41B Jun/2025
Sanofi EUR 21.76B 530M Sep/2025
UCB EUR 3.03B 12M Dec/2024
Vertex Pharmaceuticals USD 1.83B 307.4M Sep/2025